Drug Database
Back to search

France· FR:67481345

APROVEL 150 mg, comprimé pelliculé

A irbesartan product containing irbésartan, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C09CA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAPROVEL 150 mg, comprimé pelliculéATCC09CA04REGISTER NO.FR:67481345PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about irbésartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Irbesartan is registered in 18 of 19 countries.

Countries holding a registration under ATC C09CA04 (irbesartan), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search irbesartan products by name

Irbesartan · ATC C09CA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of irbesartan costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.14 in France to $0.68 in Switzerland — a ×4.7 gap.

  • France: $0.14 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Irbesartan · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.68
  • ES Spain$0.31
  • IT Italy$0.26
  • US United States$0.16 (acquisition cost)
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
IRBÉSARTAN
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
C09CA04
ATC class
Irbesartan
Defined daily dose
0.15 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400938014792
    2 plaquette(s) thermoformée(s) PVC PVDC aluminium de 15 comprimé(s)
    EUR 5.29
  • cip13
    3400938014853
    6 plaquette(s) thermoformée(s) PVC PVDC aluminium de 15 comprimé(s)
    EUR 15.76

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for irbesartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check irbesartan against other medicinesHow interaction checks work

Irbesartan · interactions on record

371 records

  • 7 severe
  • 128 moderate
  • 3 minor
  • 152 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Irbesartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All irbesartan products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Irbepress, Irbesartan Hexal
  • Belgium · Irbesartan Eg, Irbesartan Sandoz
  • Bulgaria · Ирбесан, Ирбесо
  • Cyprus · Converium, Irbesartan Vocate
  • Czechia · Isame
  • Germany · Irbepress, Irbesartan 1 A Pharma
  • Denmark · Irbesartan Accord, Irbesartan Jubilant
  • Spain · Irbesartán Almus, Irbesartán Alter
  • United Kingdom (Northern Ireland) · Irbesartan, Irbesartan Accord
  • Greece · Besartan, Irbegen
  • Hungary · Irabel, Irbesartan Sandoz
  • Ireland · Irbesartan Clonmel, Irbesartan Rowa
  • Iceland · Aprovel, Ifirmasta
  • Italy · Abesart, Irbesartan Accord
  • Liechtenstein · Aprovel, Irbesartan Teva
  • Luxembourg · Irbesartan Eg, Irbesartan Viatris
  • Malta · Irbesartan Aurobindo Pharma (Malta)
  • Netherlands · Artibesan, Irbesartan Accord
  • Norway · Aprovel, Ifirmasta
  • Poland · Irbesartan Aurovitas
  • Portugal · Irbesartan Alter, Irbesartan Aurovitas
  • Romania · Irbesartan Terapia
  • Sweden · Irbesartan Accord, Irbesartan Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94f4a50d-f351-45d3-af99-93b18892e752
GET /v1/drugs/94f4a50d-f351-45d3-af99-93b18892e752?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67481345",
  "date_amm": "2004-03-02",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/97/046",
  "substance": "IRBÉSARTAN",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about irbesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console